We also found that RUNX1 can regulate the transcription and expression of IFNGR2 and is involved in the regulation of glioma cell proliferation, cycle, apoptosis, invasion, and migration, and the differentiation process of glioma mutant subtypes. The gene discussed is IFNGR2; the disease is central nervous system cancer.